Topical 0.1% alitretinoin gel for classic Kaposi sarcoma [9]

Archives of Dermatology

Volumn 138, Issue 4, 2002, Pages 542-543

  Morganroth, Greg S ^a  

^a Orchard Creek Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN;

AGED; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; EXCISION; FEMALE; GEL; HUMAN; KAPOSI SARCOMA; LASER SURGERY; LETTER; PRIORITY JOURNAL; TOPICAL TREATMENT; TREATMENT OUTCOME;

EID: 0036220497     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.138.4.542     Document Type: Letter

References (4)

1. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel
2. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: Results of phase 1 and 2 trials
3. Topical 9-cis-retinoic acid (Panretin®) gel as treatment of cutaneous AIDS-related Kaposi's sarcoma: Interim results of an international, placebo-controlled trial (ALRT1057-503)
4. Efficacy and safety of long-term alitretinoin gel (Panretin®) for cutaneous AIDS-related Kaposi's sarcoma